Privacy Policy
Signals Blog

Contributors

Categories

What not to miss at #TMM2014

> Next week, close to 500 researchers, clinicians, trainees, industry and government representatives will gather in Ottawa for some of the best the stem cell and regenerative medicine research community has to offer. The third Till & McCulloch Meetings is...

Update from the Clinic: September

. Welcome to your Update from the Clinic for the month of September. There’s a mixture of news from the cancer stem cell companies and immunotherapy companies this past month. Amongst other things, the FDA removed the previously imposed partial hold on one of...

Regenerative Medicine Deal Review: September

Welcome to your deal review for the month of September. There was some healthy news flow around cell-based immunotherapy companies this past month, heating up a space that is already ablaze with activity. Undoubtedly the company that took the spotlight was...

Right Turn: There’s beauty in science

. The colourful, beautiful, whimsical, original, intriguing (I could go on) images that were submitted to CCRM for its Cells I See contest are live on Facebook for your viewing pleasure and votes. Until October 18, 2014 people are encouraged to “like” their favourite...

Of seismic waves and closing days: take home messages

. With contributions from James Smith, a recent Oxford University graduate and current SENS Research Foundation Summer Scholar working at the Harvard Stem Cell Institute. There were two momentous events on the night of August 23, 2014. First, the inaugural...

More than just the pizza: A new approach to Journal Club

> It’s September again! That means new grad students in the lab, seminars and courses start again, committee meetings, grant deadlines, product shows, and… Journal Club. What is Journal Club – and why am I about to spend an entire post talking about it? Ideally, it...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!